Neurocrine Biosciences reported $169M in Debt for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Debt Change
Acadia Pharmaceuticals ACAD:US $ 0M 0M
Acorda Therapeutics ACOR:US $ 184.98M 2.54M
Agios Pharmaceuticals AGIO:US $ 1.22M 0.7M
ALKERMES ALKS:US $ 294.54M 0.63M
Alnylam Pharmaceuticals ALNY:US $ 677.72M 1.01M
Amgen AMGN:US $ 36522M 332M
Biogen BIIB:US $ 7277.2M 2M
Biomarin Pharmaceutical BMRN:US $ 1081.05M 0.99M
Cytokinetics CYTK:US $ 197.02M 0.96M
Dynavax Technologies DVAX:US $ 221.03M 0.27M
Enanta Pharmaceuticals ENTA:US $ 1.51M 0M
Exelixis EXEL:US $ 0M 0M
Halozyme Therapeutics HALO:US $ 877.64M 0.97M
Intercept Pharmaceuticals ICPT:US $ 713.86M 3.03M
Intra Cellular Therapies ITCI:US $ 0M 0M
IONIS PHARMACEUT IONS:US $ 1252.14M 23.19M
Nektar Therapeutics NKTR:US $ 0M 0M
Neurocrine Biosciences NBIX:US $ 169M 208.7M
Prothena PRTA:US $ 0M 0M
Regeneron Pharmaceuticals REGN:US $ 2700.7M 0.3M
Repligen RGEN:US $ 283.71M 0.44M
Rigel Pharmaceuticals RIGL:US $ 29.84M 0.01M
Sarepta Therapeutics SRPT:US $ 1100.87M 2.03M
Teva Pharmaceutical TEVA:IT 22.08B 835M
Ultragenyx Pharmaceutical RARE:US $ 0M 0M
Vertex Pharmaceuticals VRTX:US $ 531.6M 36.1M
Xoma XOMA:US $ 0 0
YTE INCY:US $ 34.19M 0.01M